Gebretekle GB, Yeung MW, Ximenes R, Cernat A, et al. Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants. Vaccine 2024 Jul 29:126164. doi: 10.1016/j.vaccine.2024.126164.
PMID: 39079810